linzesshcp.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
#updated 08/15/2022 User-agent: * Disallow: */jcr Disallow: /*.iframe.html Disallow: /*api Disallow: /*bin/ Disallow: /*bin/abbvieforms/refreshlogin Disallow: /DSARegistration Disallow: /_jcr_content/ Disallow: /api/* Disallow: /content/dam/formsanddocuments/ Disallow: /content/forms/af/ Disallow: /content/usergenerated/content/forms/af/ Disallow: /content/usergenerated/content/forms/af/* Disallow: /favicon.ico Disallow: /form-contact-a-rep/ Disallow: /form-financial-support/ Disallow: /generatepdf* Disallow: /jcr* Disallow: /landing* Disallow: /page-not-found* Disallow: /search-results* Disallow: /system-error* Disallow: /thank-you* Sitemap: www.linzesshcp.com/sitemap.xml # End
Meta Tags
Title LINZESS® (linaclotide) | For HCPs | For IBS-C & CIC
Description Her IBS-C is more than Information for HCPs on LINZESS® (linaclotide), a prescription medication that treats Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
Keywords Generic Indication
Server Information
WebSite linzesshcp faviconlinzesshcp.com
Host IP 72.52.10.14
Location United States
Related Websites
Site Rank
More to Explore
linzesshcp.com Valuation
US$11,799,722
Last updated: 2023-04-28 08:20:39

linzesshcp.com has Semrush global rank of 896,996. linzesshcp.com has an estimated worth of US$ 11,799,722, based on its estimated Ads revenue. linzesshcp.com receives approximately 1,361,507 unique visitors each day. Its web server is located in United States, with IP address 72.52.10.14. According to SiteAdvisor, linzesshcp.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$11,799,722
Daily Ads Revenue US$10,893
Monthly Ads Revenue US$326,762
Yearly Ads Revenue US$3,921,139
Daily Unique Visitors 90,768
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
linzesshcp.com. A 300 IP: 72.52.10.14
linzesshcp.com. NS 86400 NS Record: ha3.markmonitor.zone.
linzesshcp.com. NS 86400 NS Record: ha4.markmonitor.zone.
linzesshcp.com. NS 86400 NS Record: ha1.markmonitor.zone.
linzesshcp.com. NS 86400 NS Record: ha2.markmonitor.zone.
linzesshcp.com. MX 14400 MX Record: 10 mxb-0015e701.gslb.pphosted.com.
linzesshcp.com. MX 14400 MX Record: 10 mxa-0015e701.gslb.pphosted.com.
linzesshcp.com. TXT 3600 TXT Record: tb95klrw59fh3l6zj5967kr563xyg2b3
linzesshcp.com. TXT 3600 TXT Record: v=spf1 mx include:spf-0015e701.pphosted.com ~all
linzesshcp.com. TXT 3600 TXT Record: google-site-verification=LZKtQLzet7qgXI0dpi3vMdFWwfB8e86j3s9s-1b1njw
HtmlToTextCheckTime:2023-04-28 08:20:39
AbbVie Access Important Safety Information Prescribing Information Patient Site ABOUT LINZESS MOA DOSING LINZESS FOR IBS-C EFFICACY SAFETY IBS-C PATIENT IDENTIFICATION LINZESS FOR CIC EFFICACY SAFETY CIC PATIENT IDENTIFICATION SUPPORT SAMPLES & SAVINGS COVERAGE REQUEST A REP ADDITIONAL RESOURCES PATIENT SITE LINZESS ® (linaclotide) is indicated in adults for the treatment of both irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). 1 Her IBS-C is more than constipation Choose LINZESS to help relieve constipation and overall abdominal symptoms (bloating, pain, and discomfort). 1 Why wait? Not an actual patient. EFFICACY DATA SAFETY DATA PATIENT SAVINGS EFFICACY DATA SAFETY DATA PATIENT SAVINGS IMPORTANT SAFETY INFORMATION WARNING: RISK OF SERIOUS DEHYDRATION IN PEDIATRIC PATIENTS LESS THAN 2 YEARS OF AGE LINZESS is contraindicated in patients less than 2 years of age; in nonclinical studies in neonatal mice, administration of a single,
HTTP Headers
HTTP/1.1 301 Moved Permanently
cache-control: no-cache, no-store, must-revalidate
Pragma: no-cache
Expires: -1
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
X-Frame-Options: DENY
Content-Security-Policy: script-src 'self'
Location: https://www.linzesshcp.com/
Vary: Accept
Content-Type: text/plain; charset=utf-8
Content-Length: 61
Date: Thu, 21 Oct 2021 11:29:44 GMT
Connection: keep-alive
Set-Cookie: NSC_us_nbsl-83+63+21+25-91=ffffffff2fe62ef045525d5f4f58455e445a4a423660;path=/;httponly

HTTP/1.1 200 OK
Content-Type: text/html; charset=utf-8
Content-Length: 37685
Connection: keep-alive
Date: Thu, 21 Oct 2021 11:30:47 GMT
Cache-Control: no-cache, no-store
Expires: -1
Pragma: no-cache
Set-Cookie: ASP.NET_SessionId=jj3krlo1naocnspxyrwzrv4c; path=/; HttpOnly; SameSite=Lax
Set-Cookie: SC_ANALYTICS_GLOBAL_COOKIE=bf88f9f5ec9547e6943a35440f6f703b|False; path=/; HttpOnly
Strict-Transport-Security: max-age=31536000
X-Content-Type-Options: nosniff
Server: 
Vary: Accept-Encoding,Accept-Encoding
X-Cache: Miss from cloudfront
Via: 1.1 91e7f6dd5130ccc0c1247b2da038e3de.cloudfront.net (CloudFront)
X-Amz-Cf-Pop: ORD52-C2
X-Amz-Cf-Id: Xhyc-uOXsBzSjZteM2SqXQliSxdAYWNU7y86GU80w1WzC1YOLgEfmA==
linzesshcp.com Whois Information
Domain Name: LINZESSHCP.COM
Registry Domain ID: 1741200394_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2021-07-27T09:20:38Z
Creation Date: 2012-08-28T18:36:24Z
Registry Expiry Date: 2022-08-28T18:36:24Z
Registrar: MarkMonitor Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: abusecomplaints@markmonitor.com
Registrar Abuse Contact Phone: +1.2083895740
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: HA1.MARKMONITOR.ZONE
Name Server: HA2.MARKMONITOR.ZONE
Name Server: HA3.MARKMONITOR.ZONE
Name Server: HA4.MARKMONITOR.ZONE
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-10T05:15:13Z <<<